Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(4.49)
# 1,091
Out of 5,032 analysts
215
Total ratings
63.5%
Success rate
16%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STVN Stevanato Group | Rated: Hold | $20 | $19.86 | +0.70% | 16 | Oct 5, 2026 | |
| WST West Pharmaceutical Services | Upgraded: Buy | $365 → $400 | $372.64 | +7.34% | 11 | Sep 22, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $300 | $304.96 | -1.63% | 9 | Sep 21, 2026 | |
| GRAL GRAIL | Reiterated: Hold | $60 | $137.28 | -56.29% | 7 | Sep 21, 2026 | |
| MMED MiniMed Group | Rated: Buy | $19 → $21 | $19.64 | +6.92% | 4 | Sep 18, 2026 | |
| IQV IQVIA Holdings | Rated: Hold | $240 → $270 | $259.98 | +3.85% | 7 | Sep 17, 2026 | |
| NTRA Natera | Reiterated: Buy | $355 | $400.65 | -11.39% | 7 | Sep 14, 2026 | |
| WAT Waters | Reiterated: Hold | $430 | $436.43 | -1.47% | 6 | Sep 14, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $175 | $169.33 | +3.35% | 8 | Sep 1, 2026 | |
| HTFL HeartFlow | Reiterated: Hold | $35 → $40 | $50.69 | -21.09% | 2 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $37 → $40 | $80.66 | -50.41% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5.5 | $5.38 | +2.23% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $175 → $185 | $170.69 | +8.38% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1,275 → $1,450 | $1,533.07 | -5.42% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $47 → $44 | $44.65 | -1.46% | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $215.61 | +2.04% | 9 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $22 | $26.90 | -18.22% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $14 | $15.43 | -9.27% | 2 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $620 → $650 | $656.58 | -1.00% | 5 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $71.98 | -2.75% | 5 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $9 → $13 | $16.03 | -18.90% | 4 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $68 | $76.43 | n/a | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $182 | $68.20 | n/a | 12 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $160 | $107.20 | n/a | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $15 | $5.95 | n/a | 11 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $4.00 | n/a | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $19.55 | n/a | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $260 | $317.05 | n/a | 12 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $11 | $10.54 | n/a | 4 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $4 | $8.56 | n/a | 14 | Dec 3, 2024 |
Stevanato Group
Oct 5, 2026
Rated: Hold
Price Target: $20
Current: $19.86
Upside: +0.70%
West Pharmaceutical Services
Sep 22, 2026
Upgraded: Buy
Price Target: $365 → $400
Current: $372.64
Upside: +7.34%
Charles River Laboratories International
Sep 21, 2026
Reiterated: Buy
Price Target: $300
Current: $304.96
Upside: -1.63%
GRAIL
Sep 21, 2026
Reiterated: Hold
Price Target: $60
Current: $137.28
Upside: -56.29%
MiniMed Group
Sep 18, 2026
Rated: Buy
Price Target: $19 → $21
Current: $19.64
Upside: +6.92%
IQVIA Holdings
Sep 17, 2026
Rated: Hold
Price Target: $240 → $270
Current: $259.98
Upside: +3.85%
Natera
Sep 14, 2026
Reiterated: Buy
Price Target: $355
Current: $400.65
Upside: -11.39%
Waters
Sep 14, 2026
Reiterated: Hold
Price Target: $430
Current: $436.43
Upside: -1.47%
Agilent Technologies
Sep 1, 2026
Reiterated: Buy
Price Target: $175
Current: $169.33
Upside: +3.35%
HeartFlow
Aug 17, 2026
Reiterated: Hold
Price Target: $35 → $40
Current: $50.69
Upside: -21.09%
Aug 10, 2026
Rated: Hold
Price Target: $37 → $40
Current: $80.66
Upside: -50.41%
Aug 6, 2026
Reiterated: Hold
Price Target: $5.5
Current: $5.38
Upside: +2.23%
Aug 4, 2026
Rated: Buy
Price Target: $175 → $185
Current: $170.69
Upside: +8.38%
Aug 4, 2026
Rated: Hold
Price Target: $1,275 → $1,450
Current: $1,533.07
Upside: -5.42%
Aug 4, 2026
Rated: Sell
Price Target: $47 → $44
Current: $44.65
Upside: -1.46%
Aug 3, 2026
Reiterated: Buy
Price Target: $220
Current: $215.61
Upside: +2.04%
Jul 30, 2026
Reiterated: Hold
Price Target: $20 → $22
Current: $26.90
Upside: -18.22%
Jul 30, 2026
Reiterated: Hold
Price Target: $10 → $14
Current: $15.43
Upside: -9.27%
Jul 24, 2026
Reiterated: Buy
Price Target: $620 → $650
Current: $656.58
Upside: -1.00%
Jul 10, 2026
Reiterated: Buy
Price Target: $70
Current: $71.98
Upside: -2.75%
Jul 9, 2026
Rated: Hold
Price Target: $9 → $13
Current: $16.03
Upside: -18.90%
Jul 15, 2025
Reiterated: Buy
Price Target: $100 → $68
Current: $76.43
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: $200 → $182
Current: $68.20
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $130 → $160
Current: $107.20
Upside: n/a
May 20, 2025
Reiterated: Hold
Price Target: $20 → $15
Current: $5.95
Upside: n/a
May 9, 2025
Reiterated: Hold
Price Target: $10
Current: $4.00
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $19
Current: $19.55
Upside: n/a
Apr 24, 2025
Reiterated: Hold
Price Target: $260
Current: $317.05
Upside: n/a
Feb 27, 2025
Reiterated: Hold
Price Target: $10 → $11
Current: $10.54
Upside: n/a
Dec 3, 2024
Reiterated: Hold
Price Target: $5 → $4
Current: $8.56
Upside: n/a